Son Dönem Böbrek Yetmezliğinde Nutrisyon Desteği

Kronik böbrek yetmezliği (KBY), glomerül filtrasyon hızının (GFR) böbrek işlevlerinde saptanabilir düzeyde değişikliklere neden olacak kadar, kalıcı bir şekilde azaldığı durum olarak tanımlanabilir. Bu durum genellikle GFR 25 mL/dk/1.73 m2’nın altına indiğinde ortaya çıkar. Son dönem böbrek yetmezliği (SDBY), endojen renal fonksiyonunun irreversibl kaybı ile karakterize ve hayatı tehdit eden üremiden korunmak için hastaya devamlı olarak diyaliz veya transplantasyon gibi renal replasman tedavilerinin uygulandığı klinik tabloyu oluşturur. SDBY insidansı ve prevalansı tüm dünyada artmaktadır. Türk Nefroloji Derneği verilerine göre son 10 yılda ülkemizde SDBY insidansında iki kat, prevalansında beş kat artış gözlenmiştir. Kronik böbrek yetmezliğine eşlik eden üremik sendrom iştah kaybıyla, azalmış oral besin alımıyla sonuçlanan gastrointestinal yan etkilerle, metabolik asidoz, endokrin etmenler, üremik toksisite, protein katabolizmasının başlamasıyla vb. ilişkilidir. Malnütrisyon SDBY olan hastalarda önemli bir sorundur. SDBY tanısı konmuş hastalarda protein enerji malnutrisyonunun (PEM) bulunma oranı hemodiyaliz (HD) hastalarında %18-75, sürekli ayaktan periton diyaliz (SAPD) hastalarında %10-50 arasındadır. Protein enerji malnütrisyon varlığı SDBY’de artmış mortalite ve morbidite ile ilişkilidir. Malnütrisyon sık görüldüğü için, beslenme durumunun periyodik olarak değerlendirilmesi, erken tanı ve uygun tedavide diyaliz hastalarının rutin bakımının bir parçasıdır. Öncelikle tıbbi beslenme tedavisi bireysel olarak düzenlenmeli, oral yolla yeterli enerji ve besin ögesi alamayan hastalar ve beden kütle indeksi

Nutritional Support in End-Stage Renal Disease

Chronic kidney disease (CKF) is a state of permanent decrease in glomerular filtration rate (GFR) that will cause established changes in kidney functions. This status usually occurs when GFR decreases below 25mL/min/1.73m2. End Stage Renal Disease (ESRD)is characterized with irreversible loss of renal functions and this constitutes a clinical state that requires renal replacement treatments such as dialysis and transplantation in order to be protected from harmful and life threatening effects of uremia. The incidence and prevalence of ESRD is increasing globally. According to the data of the Turkish Nephrology Society, ESRD incidence was increased two times and prevalence was increased five times in the last 10 years in Turkey. Uremia decreases appetite and causes reduced food intake that is related with its negative effects on the gastrointestinal system function, metabolic acidosis, endocrine factors, uremic toxicity, induction of protein catabolism, etc. Protein energy malnutrition (PEM) is an important problem in ESRD. PEM rates of the hemodialysis and peritoneal dialysis patients are 18-75% and 10-50 %, respectively. Protein energy malnutrition in ESRD is strongly related with increased morbidity and mortality. As a result of the frequency of malnutrition, periodic assessment of nutritional status should be part of the routine care of dialysis patients to permit early recognition and the institution of appropriate therapy. The first step is to modify of the diet for each individual. Nutritional support is indicated in undernourished ESRD patients as defined by low nutritional indices, mainly body mass index less than 20 kg/m2, body weight loss more than 10% over 6 months, serum albumin less than 3.5 g/dL and serum prealbumin less than 30 mg/ dL and in cases where normal food intake is inadequate. If the patients can’t tolerate oral nutritional supplements, early enteral nutrition with tube feeding is recommended. If the patients can’t tolerate enteral nutrition with tube feeding, then parenteral nutrition or intradialytic parenteral nutrition in hemodialysis patients is offered.

___

  • 1.Widmaier EP, Raff H, Strang KT. Böbrekler, su ve inorganik iyonların düzenlenmesi. Demirgören S, Editör. Vander İnsan Fizyolojisi. 10. Baskı, İzmir, Güven Kitabevi;2010.
  • 2.Tanrıverdi MH, Karadağ A, Hatipoğlu EŞ. Kronik böbrek yetmezliği. Konuralp Tıp Dergisi 2010; 2(2):27-32.
  • 3.Levey AS, Eckardt KU. Definition and classification of chronic kidney disease. A position statement from Kidney Disease: Improving Global Outcomes. Kidney Int 2005;67:2089-2100.
  • 4.National Kidney Foundation- K/DOQI Clinical practice guidelines for chronic kidney disease. Evalution classification and stratification. Am J Kidney Dis 2002;39(2) (suppl 1):S1-S266.
  • 5.U.S. Renal Data System.USRDS 2012 Annual data report: Atlas of chronic kidney disesase and end-stage renal disease in the United States.Incidence, prevalence,patient c h a r a c t e r i s t i c s . h t t p : / / w w w. u s r d s . o r g / a d r. a s p x Erişim:29.11.2012.
  • 6.Süleymanlar G, Seyami N, Altıparmak M. Türkiye’de Nefroloji- Diyaliz ve Transplantasyon. Türk Nefroloji Derneği kayıt sistemi 2011 Yılı rapor özeti. Türk Nefroloji Derneği Yayınları, İstanbul,2012.
  • 7.Yeniçerioğlu Y. Kronik böbrek hastalığı epidemiyolojisi. Türkiye Klinikleri J Nephrol 2008;1(2):1-5.
  • 8.Wilkens KG, Juneja V, Shanaman E. Medical nutrition therapy for renal disorders. Ed. Mahan LK, Escott- Stump, S, Raymond J. Krause’s Food and Nutrition Care Process.13th Ed, USA:Saunders Elsevier, 2012, p.799-831.
  • 9.Sezer S, Arat Z, Özdemir FN. Kronik böbrek yetmezliğinde malnütrisyon. Türk Nefroloji ve Transplantasyon Dergisi 2000;3:125-129.
  • 10.Caimi G, Carollo C, Presti R. Pathophysiological and clinical aspects of malnutrition in chronic renal failure. Nutr Res Rev 2001;21:343-379.
  • 11.Chertow GM, Ackert K, Lew NL, Lazarus JM, Lowrie EG. Prealbumin is as important as albumin in the nutritional assesment of hemodialysis patients. Kidney International 2000;58(6):2512–2517.
  • 12.Qureshi AR, Alvestrand A, Divino-Filho JC, et al. Inflammation, malnutrition, and cardiac disease as predictors of mortalitity in hemodialysis patients. Journal of American Social Nephrology, 2001;13:S28-S36.
  • 13.Lindholm B, Heimbürger O, Stenvinkel P. What are the causes of protein energy malnutrition in Chronic Renal Insufficiency? Am J Kidney Dis 2002;39(2):422-425.
  • 14.Pupim LB, İkizler A. Assessment and monitoring of uremic malnutrition. Journal of Renal Nutrition, 2004;14:6-9.
  • 15.Locatelli F, Fouque D, Heimburger O, Drüeke TB, Canata- Andia JB, Hörl W, Ritz W. Nutritional status in dialysis patients: A european concensus. Nephrology Dialysis Transplantation 2002;17:563-572.
  • 16.Kopple JD. Rationale for an International Federation of Kidney Foundations. Am J Kidney Dis 2000;36:1059- 1070.
  • 17.Lindsay R. The nutritional status of chronic renal failure patients following the initiation of hemodialysis treatment. Am J of Kidney Dis 2002;40(1):205-207.
  • 18.Oğuzhan N, Utaş C. Kronik Böbrek Yetmezliğinde Malnütrisyon. Türkiye Klinikleri J Nephrol-Special Topics 2009;2(2):26-33.
  • 19.Young GA, Koople JD, Lindholm B, et al. Nutritional assessment of continuous peritoneal dialysis patients: An international study. American Journal of Kidney Disease 1991;17:462-471.
  • 20.Ash S, Campbell C, MacLaughlin H, et al. Evidence based practice guidelines for the nutritional management of chronic kidney disease. Nutrition Dietetics 2006;63(Suppl.2):S35-S45.
  • 21.Mehrotra R, Kopple JD. Nutritional management of maintance dialysis patients. why aren’t we going better? Annual Review of Nutrition 2001;21:343-379.
  • 22.Blumenkrantz MJ. Beslenme. Ed.Bozfakıoğlu S, Ecder T. Diyaliz El Kitabı.2.baskı, İstanbul: Nobel Tıp Kitabevi 1997 s.374-399.
  • 23.Cano N, Fiaccadori E, Tesinsky P, Toigo G, et al. ESPEN guidelines on enteral nutrition: adult renal failure. Clin Nutr 2006;25:295-310.
  • 24.Kopple JD. K/DOQI clinical practice guidelines for nutrition for chronic dialysis patients. Am J Kidney Dis 2001;37(1):S66-S70.
  • 25.Eknoyan G, Levin N,et al. K/DOQI clinical practice guidelines for nutrition in chronic renal failure. Am J Kidney Dis 2000;35(6) (Suppl 2) :S17-S104.
  • 26.Fouque D, Vennegoor M, Ter Wee P, Wanner C, Baser A, et al. EBPG guideline on nutrition. Nephrol Dial Transplant 2007;22(Suppl 2)ii45-ii87.
  • 27.Rocco MV, Paranondi L,Burrowes JD, et al. Nutritional status in the HEMO study cohort at baseline (HD). Am J Kidney Dis 2002;39:245-256.
  • 28.Akpınar H. Renal hastalıkta nutrisyonel destek. Ed. Haldun Gündoğdu. Klinik Nutrisyonun Temelleri.4.baskı. Ankara: Bayt Bilimsel Araştırmalar Basın Yayın ; 2013, s:473-484.
  • 29.Stratton RJ, Bircher G, Fouque D, et al. Multinutrient oral supplements and tube feeding in maintenance dialysis: a systematic review and meta-analysis. Am J Kidney Dis 2005;46:387-405.
  • 30.Toigo G, Aparicio M, Atman PO et al. Expert working group report on nutrition in adult patients with renal insufficiency (Part 2 of 2).Clin Nutr 2000;19:281-291.
  • 31.Caglar K, Fedje L, Dimmitt R, et al. Therapeutic effects of oral nutritional supplementation during hemodialysis. Kidney Int 2002;62:1054-1059.
  • 32.Cano NJ, Aparicio M, Brunori G, et al. ESPEN guidelines on parenteral nutrition: adult renal failure. Clin Nutr 2009;28:401-414.
  • 33.McCann L, Feldman C, Hornberger J, Belanger S, et al. Effect of intradialytic parenteral nutrition on delivered Kt/V. Am J Kidney Dis 1999;33:1131-1135.
  • 34.Cano N, Leverve MX. Intradialytic nutritional support. Current Opinion in Clinical Nutrition and Metabolic Care 2008;11:147-151.
  • 35.Cano N. Nutritional supplementation in adult patients on hemodialysis. J Ren Nutr 2007;17:103-105.
  • 36.Serna-Thome MG, Padilla-Rosciano AE, Suchil-Bernal L. Practical aspects of intradialytic nutritional support. Current Opinion in Clinical Nutrition and Metabolic Care 2002;5:293-296.
  • 37.Foulks CJ. The effect of intradialytic parenteral nutrition on hospitalization rate and mortality in malnourished hemodialysis patient. J Renal Nutr 1994;4:5-10.
  • 38.Cranford W. Cost-effectiveness of IDPN therapy measured by hospitalizations and length of stay. Nephrol News Issues 1998;12:33-39.
  • 39.Chertow GM, Ling J, Lew NL, Lazarus JM, Lowrie EG. The association of intradialytic parenteral nutrition administration with survival in hemodialysis patients. Am J Kid Dis 1994;24:912-920.